公司資料
Kenvue 股價、新聞與催化劑
- 股票代碼:
- KVUE
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
18.79 USD (-2.14%)
收盤價
最後更新: 2026年8月17日
33.3B USD
市值
股價為何變動
As of Aug 17, 2026, KVUE closed down 2.14% at $18.79. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Kenvue is a consumer health company focused on over-the-counter and personal care brands rather than pharmaceuticals or biotech. Its portfolio is anchored by familiar household products across skin health, oral care, and self-care.
所在地與產業分類
Headquartered in the United States and listed on NYSE, Kenvue has a global consumer-health footprint. It is a consumer products company, not a biotech or medtech business.
商業模式特徵
The business depends on brand strength, retail distribution, pricing power, and steady consumer demand. Investors watch revenue growth, margin discipline, and portfolio management rather than clinical or regulatory catalysts.
生技產業定位
Kenvue sits outside biotechnology and even outside most healthcare innovation categories. It belongs in consumer health, where brand execution and demand stability matter more than research-driven catalysts.
未來催化劑
- Kenvue’s near-term catalysts are consumer-health earnings, margin stabilization, and whether the company can keep proving the post-spin story is getting cleaner. This matters because it helps show whether the company can turn its current footprint into a cleaner earnings profile. Better execution here can matter even before a new product or trial headline lands.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。